Clinical Trial Update: A Study of Irinotecan Liposome in Advanced Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study of irinotecan liposome in advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Irinotecan liposome (liposomal irinotecan)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Advanced Pancreatic Cancer | Phase 1 | Status: COMPLETED